Antihemophilic Factor (Recombinant), Glycopegylated-Exei (Intravenous Route)
Name: Antihemophilic Factor (Recombinant), Glycopegylated-Exei (Intravenous Route)
- Antihemophilic Factor Recombinant, Glycopegylated-Exei Intravenous Route brand name
- Antihemophilic Factor Recombinant, Glycopegylated-Exei Intravenous Route injection
US Brand Name
Appropriate studies performed to date have not demonstrated pediatric-specific problems that would limit the usefulness of antihemophilic factor (recombinant), glycopegylated-exei injection in children. Safety and efficacy have been established.
There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.
Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.
Other Medical Problems
The presence of other medical problems may affect the use of this medicine. Make sure you tell your doctor if you have any other medical problems, especially:
- Allergy to hamster proteins or
- von Willebrand disease (blood clotting disorder)—Should not be used in patients with these conditions.